Adrian J. Haigh - Net Worth and Insider Trading
Adrian J. Haigh Net Worth
The estimated net worth of Adrian J. Haigh is at least $160,006 dollars as of 2024-09-20. Adrian J. Haigh is the Senior Officer of Fennec Pharmaceuticals Inc and owns about 22,223 shares of Fennec Pharmaceuticals Inc (TSX:FRX) stock worth over $160,006. Details can be seen in Adrian J. Haigh's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Adrian J. Haigh has not made any transactions after 2024-04-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Adrian J. Haigh
Adrian J. Haigh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adrian J. Haigh owns 1 companies in total, including Fennec Pharmaceuticals Inc (TSX:FRX) .
Click here to see the complete history of Adrian J. Haigh’s form 4 insider trades.
Insider Ownership Summary of Adrian J. Haigh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:FRX | Fennec Pharmaceuticals Inc | 2024-04-23 | Senior Officer |
Adrian J. Haigh Latest Holdings Summary
Adrian J. Haigh currently owns a total of 1 stock. Adrian J. Haigh owns 22,223 shares of Fennec Pharmaceuticals Inc (TSX:FRX) as of April 23, 2024, with a value of $160,006.
Latest Holdings of Adrian J. Haigh
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:FRX | Fennec Pharmaceuticals Inc | 2024-04-23 | 22,223 | 7.20 | 160,006 |
Holding Weightings of Adrian J. Haigh
Adrian J. Haigh Form 4 Trading Tracker
According to the SEC Form 4 filings, Adrian J. Haigh has made a total of 12 transactions in Fennec Pharmaceuticals Inc (TSX:FRX) over the past 5 years, including 6 buys and 6 sells. The most-recent trade in Fennec Pharmaceuticals Inc is the acquisition of 22,223 shares on April 23, 2024, which cost Adrian J. Haigh around $69,487.
Insider Trading History of Adrian J. Haigh
- 1
Adrian J. Haigh Trading Performance
GuruFocus tracks the stock performance after each of Adrian J. Haigh's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adrian J. Haigh is -33.01%. GuruFocus also compares Adrian J. Haigh's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adrian J. Haigh within 3 months outperforms 0 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adrian J. Haigh's insider trading performs compared to the benchmark.
Performance of Adrian J. Haigh
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -28.58 |  | | | | |
| Relative Return to S&P 500(%) | -33.93 | | | | | |
Adrian J. Haigh Ownership Network
Adrian J. Haigh Owned Company Details
What does Fennec Pharmaceuticals Inc do?
Who are the key executives at Fennec Pharmaceuticals Inc?
Adrian J. Haigh is the Senior Officer of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include Director & Senior Officer Rostislav Christov Raykov , and Senior Officer Robert Christopher Andrade .
Fennec Pharmaceuticals Inc (TSX:FRX) Insider Trades Summary
Over the past 18 months, Adrian J. Haigh made 12 insider transaction in Fennec Pharmaceuticals Inc (TSX:FRX) with a net sale of 0. Other recent insider transactions involving Fennec Pharmaceuticals Inc (TSX:FRX) include a net purchase of 10,816 shares made by Chris Anigeron Rallis , a net sale of 27,950 shares made by Robert Christopher Andrade , and a net purchase of 67,500 shares made by Rostislav Christov Raykov .
In summary, during the past 3 months, insiders sold 4,862 shares of Fennec Pharmaceuticals Inc (TSX:FRX) in total and bought 0 shares, with a net sale of 4,862 shares. During the past 18 months, 205,144 shares of Fennec Pharmaceuticals Inc (TSX:FRX) were sold and 388,843 shares were bought by its insiders, resulting in a net purchase of 183,699 shares.
Fennec Pharmaceuticals Inc (TSX:FRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fennec Pharmaceuticals Inc Insider Transactions
Adrian J. Haigh Mailing Address
Above is the net worth, insider trading, and ownership report for Adrian J. Haigh. Currently GuruFocus does not have mailing address information for Adrian J. Haigh.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
